{
    "Trade/Device Name(s)": [
        "Nova Max Uric Acid Monitoring System"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K160990",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043546"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "PTC"
    ],
    "Summary Letter Date": "April 4, 2017",
    "Summary Letter Received Date": "April 5, 2017",
    "Submission Date": "April 10, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1775"
    ],
    "Regulation Name(s)": [
        "Uric acid test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Uric Acid"
    ],
    "Specimen Type(s)": [
        "Capillary Whole Blood"
    ],
    "Specimen Container(s)": [
        "Single-use, auto-disabling Lancing Device"
    ],
    "Instrument(s)/Platform(s)": [
        "Nova Max Uric Acid Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic (uricase) amperometric biosensor"
    ],
    "Methodologies": [
        "Enzymatic biosensor detection"
    ],
    "Submission Type(s)": [
        "System",
        "Monitor",
        "Test Strip",
        "Control Solution",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Nova Max Uric Acid Monitoring System for measuring uric acid in capillary whole blood using an enzymatic biosensor.",
    "Indications for Use Summary": "Quantitative measurement of uric acid in fresh capillary whole blood from the fingertip of gout patients for self-testing to monitor uric acid control, intended for single-patient home use by prescription.",
    "fda_folder": "Clinical Chemistry"
}